Sotera Health Company (NasdaqGS: SHC)
Health Care · Life Sciences Tools & Services · US
$18.06
-0.88% today · +17.7% 1Y
Sotera Health Company (NasdaqGS: SHC) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $5.15B and employs 3,000 people.
Over the last twelve months the share price has gained 17.7%, trading between 13.09 and 19.85.
Tweenvest scores Sotera Health Company across four factors: quality 67/100, value 50/100, growth 54/100. Its strongest factor is quality.
SHC price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $5.15B
- Revenue (TTM)
- $1.22B
- P/E
- 31.84
- EPS
- 0.57
- Dividend yield
- —
- Beta (5Y)
- 1.86
- 52-week high
- $19.85
- 52-week low
- $13.09
- Avg volume (3M)
- —
- Shares outstanding
- 285.37M
- Employees
- 3,000
- Next earnings
- —
About Sotera Health Company
Sotera Health Company, headquartered in Broadview Heights, Ohio, delivers essential sterilization, laboratory testing, and advisory services to a global clientele spanning North America, Europe, and various international regions. The firm's sterilization capabilities encompass gamma and electron beam irradiation, alongside ethylene oxide (EO) processing. Through its Nelson Labs division, Sotera Health conducts comprehensive microbiological and analytical chemistry analyses. Additionally, it offers specialized consulting to the medical device and biopharmaceutical industries. Sotera Health serves a diverse array of sectors, including medical device manufacturers, pharmaceutical companies, producers of food and agricultural products, and various commercial, advanced, and specialty application industries. Incorporated in 2017, the company was previously known as Sotera Health Topco, Inc., adopting its current name in October 2020.
- ISIN
- US83601L1026
- Founded
- 2015
- Listed since
- Nov 20, 2020
- Exchange
- Nasdaq Global Select
- Currency
- USD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Bachem Holding AGSWX: BANB | $7.22B | CHF80.05 | +2.76% |
| Hangzhou Tigermed Consulting Co., LtdSZSE: 300347 | $6.56B | CN¥55.18 | -5.51% |
| Joinn Laboratories(China)Co.,Ltd.SHSE: 603127 | $5.35B | CN¥52.60 | +6.69% |
| Stevanato Group S.p.A.NYSE: STVN | $5.30B | $19.40 | +0.99% |
| Anthem Biosciences LimitedNSEI: ANTHEM | $5.02B | Rs862.30 | +0.77% |
| Adaptive Biotechnologies CorporationNasdaqGS: ADPT | $4.23B | $26.49 | +1.53% |
| MGI Tech Co., Ltd.SHSE: 688114 | $4.18B | CN¥67.95 | -5.49% |
| AbCellera Biologics Inc.NasdaqGS: ABCL | $4.07B | $12.55 | +4.37% |
Figures last refreshed Oct 11, 2026.